Labshake search
Citations for Tocris :
1 - 50 of 772 citations for Mouse Anti Human Immunodeficiency Virus HIV 1 gp41 1911 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... media+IL4+LPS+VIP (50ng/ml, Tocris 1911) or ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml recombinant human/mouse FGF8b (Tocris) between days 1-11 (range tested ...
-
bioRxiv - Physiology 2024Quote: Overnight recovered mouse or human islets were cultured with 0.1% DMSO (vehicle) or 9 µM AGK2 (Tocris), 25 µM AK-1 (EMD-Millipore) ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Biochemistry 2020Quote: ... human BDNF (2837, Tocris), PACAP-38 (4031157 ...
-
bioRxiv - Neuroscience 2022Quote: ... human ghrelin (Tocris, 1463), recombinant mouse leptin (Cedarlane Laboratories Ltd ...
-
bioRxiv - Neuroscience 2020Quote: ... rabbit anti-GLT-1 (Tocris, #2063, dilution 1:2000). Secondary antibodies against mouse ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were resuspended in human embryonic stem cell (hESC) medium without bFGF2 supplemented with 1 µM dorsomorphin (Tocris), 3 µM CHIR99021 (Axon Medchem) ...
-
bioRxiv - Immunology 2023Quote: ... the human Aβ42 peptide (Tocris Bioscience) was dissolved at a concentration of 100 nM in 50 μ𝓁 of 0.1 M sodium bicarbonate coating buffer (pH 8.6) ...
-
bioRxiv - Pathology 2022Quote: About 0.1 to 0.2 MOI (Multiplicity of Infection) equivalent of VSV-G and pseudotype SARS-CoV-2 spike virus particles were treated with recombinant LL37 (Tocris) and niacinamide (vitamin B3 ...
-
bioRxiv - Developmental Biology 2021Quote: ... 7 μg/ml human recombinant Insulin (Tocris), 100 ng/ml recombinant human/mouse FGF8b (Tocris ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were treated with 1µM of recombinant human A83-01 (TOCRIS), or 20ng/ml recombinant TGF-β (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... at which point 50nM CRF (human/rat, Cat. No 1151, Tocris) was added to the bath ...
-
bioRxiv - Neuroscience 2022Quote: ... the mouse was subcutaneously administered CNO (Tocris) to bilaterally inactivate the pLTN ...
-
bioRxiv - Cell Biology 2021Quote: ... and human vasopressin type 2 receptor (V2R) with [Arg8]-vasopressin (AVP; Tocris 2935, in water). The transfected β-arrestins are of bovine origin ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: Lyophilized and HPLC-purified Human β-Amyloid1-42 (Aβ1-42) peptide was purchased from Tocris (#1428). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP ...
-
bioRxiv - Cell Biology 2021Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2µM Gö6983 (Tocris). For PXGL ...
-
bioRxiv - Immunology 2023Quote: ... The scFv library was subjected to four rounds of bio-panning against the human Aβ42 peptide (Tocris Bioscience Amyloid β-Peptide 1-42 human ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Organoid Growth Medium (HOGM): 50 µl of HOGM consisted of 25 µl A83-01 (1mM, Tocris), 50 µl Human Epidermal Growth Factor (hEGF ...
-
Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome modelbioRxiv - Animal Behavior and Cognition 2021Quote: ... Each mouse was given either vehicle (artificial cerebrospinal fluid solution, Tocris Bioscience ...
-
bioRxiv - Genomics 2019Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2 μM Gö6983 (PKCi; Tocris) on Matrigel–coated plates (Corning) ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 nM gastrin, 100 ng/ml recombinant human NRG1 (RD, 5898-NR) and 500 nM A83-01 (Tocris). Human mini-colons were maintained for 14 and 21 days ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 nM gastrin, 50 ng/ml recombinant human EGF (R&D, 236-EG) and 500 nM A83-01 (Tocris). Organoids were passaged every 4 days by physical dissociation using fire-polished Pasteur pipettes.
-
bioRxiv - Molecular Biology 2021Quote: ... 1 µM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 μM DMH-1 (Tocris) and 3 μM CHIR99021 (Tocris) ...
-
bioRxiv - Immunology 2020Quote: ... Treatments of P2Y1 (MRS 2179 - 30 µM/30 μL/mouse - Tocris, Bioscience, UK) and P2Y12 (MRS 2395 - 30 µM/30 μL/mouse - Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 5 µl cannula infusions of Yoda1 (0.25 µg/mouse/injection, Tocris) or equal volume of 1% DMSO in saline for a vehicle group once a day ...
-
bioRxiv - Immunology 2023Quote: ... anti-CCR2 inhibitor (Tocris) at a dose of 75 μg per mouse twice a week ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1 μM IDE-1 and 1 μM XAV939 (both Tocris). 48 hours after the onset of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 μM endo-IWR-1 (Tocris), and 10 μM SB431542 (Stemgent).
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) on 6-well ECM collagen-I-coated peptide plates (Corning ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) and mixed with 90 μl Growth Factor Reduced Matrigel (Corning) ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...
-
bioRxiv - Biophysics 2022Quote: ... 50 μL well-1 of 2X neurotensin 1-13 (Tocris) solutions were added to the appropriate well and incubated for an additional 30 min ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 DAMGO (Tocris), 10 Bombesin (Tocris) ...
-
bioRxiv - Cell Biology 2019Quote: ... ITD-1 (Tocris) compound was administrated at 5mM.
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Neuroscience 2019Quote: ... and 1% P/S) supplemented with 1 µM purmorphamine (Tocris Bioscience), a SHH agonist ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cell Biology 2021Quote: ... and 6-O-[(4,5-Dimethoxy-2-nitrophenyl)methyl]-2,3-O-(1-methylethylidene)-D-myo-Inositol 1,4,5-tris[bis[(1-oxopropoxy)methyl]phosphate] (ci-IP3/PM; 1 μM, Tocris #6210) in imaging buffer with 0.01 % BSA in dark at room temperature ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Immunology 2019Quote: ... 1 uM capsaicin (Tocris) and 40 mM KCl (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... dAP5 (1 mM, Tocris) was topically applied to the dura mater ...